Summary & Overview
HCPCS Q4204: Xwrap per Square Centimeter (Add-on)
HCPCS Level II code Q4204 designates billing for Xwrap material charged by the square centimeter as an add-on supply in addition to a primary procedure. As an add-on HCPCS product code, Q4204 matters nationally because it affects how surgical implants and device adjuncts are reported and reimbursed across both commercial payers and Medicare. Accurate use of this code ensures the device component is separated from the primary procedure charge, which can influence payment adjudication and claims transparency.
Key payers addressed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the code’s clinical role as an adjunctive implant/device supply, the typical sites of service where it is applied (operating room or surgical suite, inpatient and outpatient settings), and common billing considerations associated with add-on HCPCS items. The publication also summarizes payer coverage patterns and common modifiers used when reporting device add-ons, and highlights areas where policy language can affect claim acceptance. Where input data is not provided, the publication notes that information is not available in the input.
Billing Code Overview
HCPCS Level II code Q4204 represents Xwrap billed per square centimeter as an add-on, list separately in addition to primary procedure. This code is used when the Xwrap product is applied and reported by the unit area treated, indicating an adjunctive implant or device component billed in addition to a primary surgical procedure.
-
Service type: Device/implant add-on product applied during a surgical procedure
-
Typical site of service: Operating room or surgical suite (inpatient or outpatient)
Clinical & Coding Specifications
Clinical Context
A 62-year-old patient with a chronic, non-healing lower extremity wound following vascular surgery presents to an outpatient wound care clinic for advanced biologic dressing placement. The clinician measures the prepared wound bed and applies a dermal regenerative matrix product billed with Q4204 billed per square centimeter as an add-on item to the primary wound debridement or closure procedure. The workflow includes wound assessment and measurement, sharp or surgical debridement as indicated, hemostasis, placement and fixation of the Q4204 material sized to the wound area, and documentation of square centimeters used. The procedure is most commonly performed in outpatient wound care centers, ambulatory surgery centers, hospital outpatient departments, or physician offices during the same encounter as the primary surgical or procedural code. Typical documentation includes wound dimensions, percentage of graft/dressing used in square centimeters, the primary procedure CPT code (for example debridement or closure), indication for the biologic dressing, and any applicable modifier to denote bilateral, increased procedural services, or multiple procedures.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier — standard reporting | Use when no additional modifier is indicated and billing as the usual add-on per-square-centimeter product. |